![EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of](https://pbs.twimg.com/media/ElPNWqDWMAAsQB-.jpg:large)
EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/2-Table1-1.png)
Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? | Journal of the American College of Cardiology Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/dff69616-31e9-406e-898a-e026864c053d/gr2.jpg)
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? | Journal of the American College of Cardiology
![Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor](https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/04/Table-1.jpg)
Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor
![Figure 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar Figure 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63e7ef97ef5bd0f249c299f7ec378b723dd0ce17/3-Figure1-1.png)
Figure 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar
![Medicina | Free Full-Text | Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study Medicina | Free Full-Text | Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study](https://www.mdpi.com/medicina/medicina-59-01881/article_deploy/html/images/medicina-59-01881-g001.png)
Medicina | Free Full-Text | Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study
CorConsult Rx - #Repost @ambcarerx ・・・ First thing you should assess when you have a patient with non-valvular AFib in clinic- CHA2DS2-VASc! 💊 With atrial fibrillation, patients have an irregularly irregular rhythm.
![Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914915019359-gr1.jpg)
Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect
![Anticoagulation rate by a CHA2DS2-VASc score. Bars show the number of... | Download Scientific Diagram Anticoagulation rate by a CHA2DS2-VASc score. Bars show the number of... | Download Scientific Diagram](https://www.researchgate.net/publication/364495659/figure/fig1/AS:11431281173778716@1689041402875/Anticoagulation-rate-by-a-CHA2DS2-VASc-score-Bars-show-the-number-of-patients-with-AF-at.png)
Anticoagulation rate by a CHA2DS2-VASc score. Bars show the number of... | Download Scientific Diagram
![A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram](https://www.researchgate.net/publication/257731952/figure/fig4/AS:669051147796487@1536525632448/A-schematic-representation-showing-the-strategy-of-anticoagulant-use-according-to-CHADS2.png)
A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram
![IJERPH | Free Full-Text | Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre IJERPH | Free Full-Text | Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre](https://www.mdpi.com/ijerph/ijerph-20-06145/article_deploy/html/images/ijerph-20-06145-g001.png)
IJERPH | Free Full-Text | Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
![Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex) Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex)](https://www.tandfonline.com/cms/asset/91626976-4ea2-46bf-913f-7d9870f96617/tacd_a_1720197_f0001_b.jpg)
Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex)
![Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología](https://static.elsevier.es/multimedia/18855857/0000006700000005/v2_201404301330/S1885585714000875/v1_201404301330/en/main.assets/gr1.jpeg)
Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología
![CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health](https://www.educateyourhealth.com/wp-content/uploads/2020/06/CHADS2-and-CHA2DS2-VASc-score-for-stroke-risk-and-HAS-BLED-score-for-bleeding-risk-on-oral-anticoagulation-in-atrial-fibrillation.jpg)
CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health
![Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? | Circulation Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? | Circulation](https://www.ahajournals.org/cms/asset/dd179c9e-7f84-4252-81ce-cb52d07ffa45/1498fig02.jpeg)